CASE STUDY | How NASK NANO Technology Redefined Respirator Standards: Innovation in Filtration and Breathability

NASK, a brand under Profit Royal Pharmaceutical Limited, was founded in 2015 and quickly ascended to a leadership position in the respirator market, particularly during the COVID‑19 pandemic. NASK's success is anchored in its innovative NASK NANO technology, a patented and award‑winning nanofiber technology that provides superior filtration efficiency while maintaining high breathability.

Product Innovation: NASK NANO Respirators

Traditional respirators typically rely on thick layers of melt‑blown fibers for filtration, which, although effective in filtering out particulates, often result in reduced breathability. This trade‑off can cause low oxygen levels in the blood, posing significant health risks to users.

Challenges with Conventional Respirators:

• Filtration vs. Breathability: Higher filtration efficiency often leads to lower breathability.
• Health Risks: Reduced breathability can lead to low oxygen levels in the blood, which is life‑threatening.

NASK's Solution: NASK NANO Technology

NASK NANO respirators address these challenges by employing a unique nanofiber technology that achieves the highest levels of filtration efficiency without compromising on breathability. The key features of NASK NANO respirators include:

• High Filtration Efficiency: Able to filter out airborne particles effectively.
• Low Pressure Drop: Ensures high breathability, reducing the risk of hypoxia.

Achievements and Recognition

One of the significant milestones for NASK NANO respirators was becoming the official supplier of respirators to all public hospital medical professionals during the COVID‑19 pandemic. This endorsement by public health institutions underscores the trust and reliability that medical professionals place in NASK’s technology.

Key Achievements:

• Official Supplier during COVID‑19: Provided respirators to all public hospitals.
• Patented Technology: NASK NANO is recognized and awarded for its innovative approach to respirator design.
• Industry Leadership: Recognized as a leader in the respirator market.

Impact

The adoption of NASK NANO respirators in medical settings during the pandemic highlights the critical role of innovative technology in addressing public health challenges. By offering a product that ensures both high filtration efficiency and breathability, NASK has set a new standard in the industry.

Conclusion

NASK, with its cutting‑edge nanofiber technology, has not only met but exceeded the rigorous demands of the healthcare sector during one of the most challenging periods in recent history. The brand’s commitment to innovation and excellence has solidified its position as an industry leader, providing critical protection to frontline workers and setting a benchmark for respirator technology.

Through the development and deployment of NASK NANO respirators, Profit Royal Pharmaceutical Limited has demonstrated the importance of balancing filtration efficiency and breathability in respiratory protective equipment, ensuring user safety and comfort without compromising on protection standards.